Raymond James Financial Portfolio holdings
Raymond James Financial, founded in 1962 by Robert James and headquartered in St. Petersburg, Florida, is a diversified financial services firm managing over $1.5 trillion in client assets as of late 2024, primarily focused on wealth management, investment banking, and brokerage services. Known for its advisor-centric model, the firm supports over 8,900 financial advisors across the U.S., Canada, and the UK, offering personalized financial planning, retirement solutions, and investment products to individuals, small businesses, and institutions. Its investment banking arm specializes in middle-market mergers, acquisitions, and equity offerings, while its Raymond James Bank provides lending and deposit services. With a reputation for a conservative, client-first culture and steady growth—including a notable acquisition of TriState Capital in 2022—Raymond James stands out as a resilient, relationship-driven player in the financial industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$809M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$396M |
| 3 |
Zoetis
ZTS
|
+$278M |
| 4 |
iShares Core MSCI Europe ETF
IEUR
|
+$268M |
| 5 |
Microsoft
MSFT
|
+$202M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$433M |
| 2 |
Medtronic
MDT
|
+$371M |
| 3 |
Bank of America
BAC
|
+$124M |
| 4 |
Corning
GLW
|
+$123M |
| 5 |
Vanguard FTSE Pacific ETF
VPL
|
+$114M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.68% |
| 2 | Financials | 8.02% |
| 3 | Industrials | 7.08% |
| 4 | Healthcare | 6.16% |
| 5 | Consumer Discretionary | 5.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5126
Riskified
RSKD
$716M
| $42.9K | ﹤0.01% |
+10,936
| New | +$48.5K |
|
5127
AdvisorShares Pure US Cannabis ETF
MSOS
$880M
| $42.7K | ﹤0.01% |
12,016
| – | – |
|
5128
Prime Medicine
PRME
$559M
| $41.9K | ﹤0.01% |
12,044
-15,000
| -55% | -$57.1K |
|
5129
Galectin Therapeutics
GALT
$348M
| $41.8K | ﹤0.01% |
14,967
+1,250
| +9% | +$3.8K |
|
|
AARD
5130
Aardvark Therapeutics
AARD
$173M
| $41.1K | ﹤0.01% |
+10,890
| New | +$113K |
|
5131
PUT
Lam Research
LRCX
$390B
| $39K | ﹤0.01% |
+300
| New | +$67.1K |
|
5132
PUT
Palantir
PLTR
$413B
| $39K | ﹤0.01% |
300
-300
| -50% | -$45.9K |
|
5133
Dawson Geophysical
DWSN
$135M
| $37.7K | ﹤0.01% |
10,893
+300
| +3% | +$830 |
|
5134
PUT
Energy Transfer Partners
ET
$69.3B
| $37.5K | ﹤0.01% |
2,500
-2,500
| -50% | -$45.8K |
|
|
PEW
5135
GrabAGun Digital Holdings
PEW
$77.9M
| $37.3K | ﹤0.01% |
12,390
+323
| +3% | +$978 |
|
5136
Opko Health
OPK
$1.02B
| $37.2K | ﹤0.01% |
32,624
-6,120
| -16% | -$7.53K |
|
5137
CALL
Adobe
ADBE
$105B
| $37K | ﹤0.01% |
100
| – | – |
|
5138
Identive
INVE
$61.9M
| $37K | ﹤0.01% |
10,000
| – | – |
|
5139
Cardiff Oncology
CRDF
$77.2M
| $36.7K | ﹤0.01% |
22,672
-4,000
| -15% | -$8.21K |
|
5140
Cognition Therapeutics
CGTX
$96.7M
| $36.1K | ﹤0.01% |
47,500
-1,000
| -2% | -$1.16K |
|
5141
Conduent
CNDT
$264M
| $35.9K | ﹤0.01% |
28,033
-29
| -0.1% | -$44 |
|
|
BLDP
5142
Ballard Power Systems
BLDP
$790M
| $35.3K | ﹤0.01% |
14,596
-347
| -2% | -$828 |
|
5143
Stereotaxis
STXS
$141M
| $35K | ﹤0.01% |
19,033
-10
| -0.1% | -$22 |
|
5144
PUT
United Parcel Service
UPS
$88.9B
| $35K | ﹤0.01% |
500
-100
| -17% | -$10.7K |
|
5145
CALL
Hecla Mining
HL
$11.3B
| $34K | ﹤0.01% |
+1,400
| New | +$31.5K |
|
5146
PUT
TSMC
TSM
$2.18T
| $34K | ﹤0.01% |
+100
| New | +$34.4K |
|
|
NNDM
5147
Nano Dimension
NNDM
$343M
| $33.9K | ﹤0.01% |
19,930
+3,128
| +19% | +$5.7K |
|
5148
SCYNEXIS
SCYX
$52M
| $32.3K | ﹤0.01% |
4,398
+224
| +5% | +$1.39K |
|
5149
Rezolute
RZLT
$452M
| $32.1K | ﹤0.01% |
+10,532
| New | +$31.6K |
|
5150
Milestone Pharmaceuticals
MIST
$152M
| $31.7K | ﹤0.01% |
26,600
| – | – |
|
Similar funds
Raymond James Financial's Q1 2026 Portfolio in Review
As of Q1 2026, Raymond James Financial held 5,490 positions worth $324B, up 0.94% from $321B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Raymond James Financial's Q1 2026 filing shows 349 new, 2,830 increased, 1,948 reduced and 210 closed positions. Its largest new stake was Lazard International Dynamic Equity ETF: 663,484 shares worth $21.1M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $433M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 16% a quarter earlier, followed by Financials and Industrials.
- Raymond James Financial's largest Q1 2026 buy was Lazard International Dynamic Equity ETF: 663,484 shares worth $21.1M.
- Raymond James Financial added most to Vanguard S&P 500 ETF in Q1 2026, an estimated $809M increase.
- Raymond James Financial's biggest Q1 2026 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $433M.
- Raymond James Financial fully exited New Gold Inc in Q1 2026, selling an estimated $19M.
- Raymond James Financial's ten largest holdings make up 21% of its $324B portfolio in Q1 2026.
- Raymond James Financial opened 349 new positions and closed 210 in Q1 2026.
- Raymond James Financial's portfolio value rose 0.94% quarter-over-quarter to $324B.
Based on Raymond James Financial's 13F filing for Q1 2026, filed 14 May 2026.